Acta Materia Medica · 2022 · 31 citations · 78 references
PharmacyPharmaceuticsPharmacologyDrug DeliveryOral Drug DeliveryTargeted Drug DeliveryBlood-brain Barrier DeliveryBlood-brain Barrier PenetrationBrain Targeted DeliveryCell-penetrating Delivery SystemsCell-penetrating PeptidesPeptide DeliveryBlood-brain Barrier Peptide TransportBlood-brain Barrier PermeabilityOral Drug Delivery SystemsParenteral Drug AdministrationPeptide Delivery SystemsPeptide-based Drug CarriersPeptide-mediated Brain TargetingTargeting Peptides
Peptides are short chains of amino acids linked by peptide bonds. Many peptides and proteins are limited by their poor enzymatic stability and permeability across the intestinal epithelial membranes and/or blood-brain barrier (BBB). Parenteral administration of these peptides is unfavorable because of procedural complications and low patient compliance with treatments. Instead, oral delivery is the preferred route of administration because it allows for self-administration and has a high degree of patient acceptability and compliance. Oral delivery of these peptides poses a major challenge, because the peptide drug must overcome both the physical and biochemical barriers of the gastrointestinal tract and BBB. An oral drug delivery system is beneficial because it can protect peptide drugs against degradation and deliver them to the brain, where they exert their pharmacological actions. The use of active-targeting ligands and/or cell-penetrating peptides increases penetration and uptake across the BBB. This review focuses on the diverse combinations of drug delivery systems, active-targeting ligands, and cell-penetrating peptides used to deliver peptides to the brain.
78
Drug delivery systems: An updated review
Gaurav Tiwari, S. Bannerjee, LK Bhati et al. · International Journal of Pharmaceutical Investigation · 2012 · 1.6K citations · Full text
Nanoparticulate systems for brain delivery of drugs
Jörg Kreuter · Advanced Drug Delivery Reviews · 2012 · 958 citations
Jeremy W. Gawryluk, Junfeng Wang, Ana C. Andreazza et al. · The International Journal of Neuropsychopharmacology · 2010 · 588 citations